Research at ResMed

We at ResMed are dedicated to innovating and changing lives, one breath at a time. That’s why we support and actively engage in research initiatives in five associated areas of clinical focus related to sleep-disordered breathing. Discover ResMed’s research and development initiatives in the five areas of clinical focus.

Diabetes research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to type 2 diabetes.

Cardiology research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to cardiology.

Chronic Obstructive Pulmonary Disease (overlap syndrome)

Obstructive Sleep Apnoea (OSA) and chronic obstructive pulmonary disease (COPD) often coexist within a patient. Learn more about overlap syndrome on our research initiative page.

Occupational health and safety research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to occupational health and safety.

Peri-operative care research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to peri-operative care.

Other research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to sleep-disordered breathing.

Clinical results for Narval CC™ – the ORCADES study

The 5-year multicentre ORCADES study demonstrated both the efficacy and compliance of the Narval CC™ MRD.

Narval CC delivers strong results

Narval CC packs custom-made comfort into a small, lightweight device, making it easy for patients to be compliant and obtain high efficacy.

Narval CC clinical research

There’s a growing body of clinical research that demonstrates the efficacy and compliance of mandibular repositioning devices (MRDs) in treating obstructive sleep apnoea and snoring. The following clinical research papers demonstrate results in particular for ResMed’s Narval CC™ MRD.